Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

CMS & FDA propose major Medicare changes | Big news for Biotronik | New imaging data on MINOCA | The first procedure of its kind

News You Need to Know Today
CMS & FDA propose major Medicare changes | Big news for Biotronik | New imaging data on MINOCA | The first procedure of its kind
Friday, April 24, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Trump administration moves to speed up Medicare coverage for breakthrough cardiology devices

CMS and the FDA say the goal is to improve patient access to medical devices that address an unmet need.

READ MORE >
approval regulations checkmark doctor
Share on Twitter Share on Facebook Share on Linkedin

Trump administration moves to speed up Medicare coverage for breakthrough cardiology devices

Share on Twitter Share on Facebook Share on Linkedin
approval regulations checkmark doctor
CMS and the FDA say the goal is to improve patient access to medical devices that address an unmet need.
READ MORE >

FDA approves 2 implantable heart devices from Biotronik

These devices were built to provide better patient data and improve clinician workflows. They will be on display at Heart Rhythm 2026 in Chicago. 

READ MORE >
 The U.S. Food and Drug Administration (FDA) has granted market clearance for Biotronik's Acticor Sky and Rivacor Sky implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) systems. The new technology will be launches at the Heart Rhythm Society (HRS) annual meeting this week. #HRS2026
Share on Twitter Share on Facebook Share on Linkedin

FDA approves 2 implantable heart devices from Biotronik

Share on Twitter Share on Facebook Share on Linkedin
 The U.S. Food and Drug Administration (FDA) has granted market clearance for Biotronik's Acticor Sky and Rivacor Sky implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) systems. The new technology will be launches at the Heart Rhythm Society (HRS) annual meeting this week. #HRS2026
These devices were built to provide better patient data and improve clinician workflows. They will be on display at Heart Rhythm 2026 in Chicago. 
READ MORE >

Researchers use multi-modality imaging to learn more about MINOCA

The combination of OCT and MRI can help provide an improved sense of clarity when managing MINOCA patients, according to new data presented at ACC.26 in New Orleans.

READ MORE >
Harmony Reynolds, MD, FACC, director of the cardiovascular clinical research center at NYU Langone Health, presented a study at the American College of Cardiology (ACC) 2026 meeting using coronary optical coherence tomography (OCT) and cardiac magnetic resonance imaging (MRI) to determine sex differences in underlying causes of myocardial infarction with no obstructive coronary arteries (MINOCA).
Share on Twitter Share on Facebook Share on Linkedin

Researchers use multi-modality imaging to learn more about MINOCA

Share on Twitter Share on Facebook Share on Linkedin
Harmony Reynolds, MD, FACC, director of the cardiovascular clinical research center at NYU Langone Health, presented a study at the American College of Cardiology (ACC) 2026 meeting using coronary optical coherence tomography (OCT) and cardiac magnetic resonance imaging (MRI) to determine sex differences in underlying causes of myocardial infarction with no obstructive coronary arteries (MINOCA).
The combination of OCT and MRI can help provide an improved sense of clarity when managing MINOCA patients, according to new data presented at ACC.26 in New Orleans.
READ MORE >

First bedside procedure of its kind performed by traveling clinicians on premature infant

The 22-week-old patient was successfully treated by a traveling cardiologist—all without being transported to the cath lab.

READ MORE >
Nicklaus Children’s Hospital patent ductus arteriosus (PDA) closure
Share on Twitter Share on Facebook Share on Linkedin

First bedside procedure of its kind performed by traveling clinicians on premature infant

Share on Twitter Share on Facebook Share on Linkedin
Nicklaus Children’s Hospital patent ductus arteriosus (PDA) closure
The 22-week-old patient was successfully treated by a traveling cardiologist—all without being transported to the cath lab.
READ MORE >

Featured Articles

Heart failure experts agree: HFmrEF should not be ignored

Data on the treatment and management of HFmrEF are limited, but a new scientific statement from the Heart Failure Society of America highlights how important it is to take this condition seriously.

READ MORE >
doctor patient elderly check up hospital
Share on Twitter Share on Facebook Share on Linkedin

Heart failure experts agree: HFmrEF should not be ignored

Share on Twitter Share on Facebook Share on Linkedin
doctor patient elderly check up hospital
Data on the treatment and management of HFmrEF are limited, but a new scientific statement from the Heart Failure Society of America highlights how important it is to take this condition seriously.
READ MORE >

When bioprosthetic mitral valves fail: Redo surgery bests transcatheter treatment after 5 years

Short-term outcomes were comparable, but long-term data revealed a significant difference in all-cause mortality.

READ MORE >
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient
Share on Twitter Share on Facebook Share on Linkedin

When bioprosthetic mitral valves fail: Redo surgery bests transcatheter treatment after 5 years

Share on Twitter Share on Facebook Share on Linkedin
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient
Short-term outcomes were comparable, but long-term data revealed a significant difference in all-cause mortality.
READ MORE >

Cardiologist makes ‘Magic,’ performs first procedure in US with new-look ablation catheter

Users guide the robotically navigated catheter using computer-controlled magnetic fields. It gained FDA approval in January.

READ MORE >
Nathan McConkey, DO, MPH, an electrophysiologist with Oregon Health & Science University (OHSU), made history when he used the Magic Magnetic Interventional Ablation Catheter.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist makes ‘Magic,’ performs first procedure in US with new-look ablation catheter

Share on Twitter Share on Facebook Share on Linkedin
Nathan McConkey, DO, MPH, an electrophysiologist with Oregon Health & Science University (OHSU), made history when he used the Magic Magnetic Interventional Ablation Catheter.
Users guide the robotically navigated catheter using computer-controlled magnetic fields. It gained FDA approval in January.
READ MORE >

In Case You Missed It

Interventional cardiologist Roxana Mehran elected ACC president

A prominent figure in the fields of interventional cardiology and women’s health is now leading the American College of Cardiology.

READ MORE >
Interventional cardiologist Roxana Mehran, MD, officially started her one-year term as the president of the American College of Cardiology (ACC) on the closing day of ACC.26, the group’s annual conference in New Orleans.
Share on Twitter Share on Facebook Share on Linkedin

Interventional cardiologist Roxana Mehran elected ACC president

Share on Twitter Share on Facebook Share on Linkedin
Interventional cardiologist Roxana Mehran, MD, officially started her one-year term as the president of the American College of Cardiology (ACC) on the closing day of ACC.26, the group’s annual conference in New Orleans.
A prominent figure in the fields of interventional cardiology and women’s health is now leading the American College of Cardiology.
READ MORE >

New stroke prevention device for TAVR holds its own in head-to-head battle with Sentinel

A new embolic protection device from Emboline was noninferior to the FDA-approved Sentinel device in terms of safety and efficacy. In addition, it captured much more TAVR-generated debris and was linked to an improved technical success rate. 

READ MORE >
Adam Greenbaum, MD, presents late-breaking data at ACC.26.
Share on Twitter Share on Facebook Share on Linkedin

New stroke prevention device for TAVR holds its own in head-to-head battle with Sentinel

Share on Twitter Share on Facebook Share on Linkedin
Adam Greenbaum, MD, presents late-breaking data at ACC.26.
A new embolic protection device from Emboline was noninferior to the FDA-approved Sentinel device in terms of safety and efficacy. In addition, it captured much more TAVR-generated debris and was linked to an improved technical success rate. 
READ MORE >

Whoop raises $575M—Abbott, LeBron James, Cristiano Ronaldo among the investors

Whoop, a Boston-based wearable technologies company, raised the new funding on a $10.1 billion evaluation.

READ MORE >
Whoop, a Boston-based wearable technologies company, has raised $575 million in new financing at a $10.1 billion valuation. Investors include Abbott, Mayo Clinic, LeBron James and Cristiano Ronaldo.
Share on Twitter Share on Facebook Share on Linkedin

Whoop raises $575M—Abbott, LeBron James, Cristiano Ronaldo among the investors

Share on Twitter Share on Facebook Share on Linkedin
Whoop, a Boston-based wearable technologies company, has raised $575 million in new financing at a $10.1 billion valuation. Investors include Abbott, Mayo Clinic, LeBron James and Cristiano Ronaldo.
Whoop, a Boston-based wearable technologies company, raised the new funding on a $10.1 billion evaluation.
READ MORE >

In Other News

An ‘AI-native’—and lavishly funded—medical center grows in Texas

The largest single component of the overall project is likely to be the high-tech, high-touch hospital that’s now slated for opening in 2030.

READ MORE >
IT professional server farm
Share on Twitter Share on Facebook Share on Linkedin

An ‘AI-native’—and lavishly funded—medical center grows in Texas

Share on Twitter Share on Facebook Share on Linkedin
IT professional server farm
The largest single component of the overall project is likely to be the high-tech, high-touch hospital that’s now slated for opening in 2030.
READ MORE >

Clinic selling electrical stimulation pain relief pays $380K to resolve fraud allegations

The U.S. Department of Justice said Wisconsin-based Apple Clinic and its owner Michael Johnson, MD, were using a combination of nerve density testing, vitamin injections and electrical stimulation to alleviate pain, billing Medicare for these medically unnecessary services. 

READ MORE >
neck_pain.jpg
Share on Twitter Share on Facebook Share on Linkedin

Clinic selling electrical stimulation pain relief pays $380K to resolve fraud allegations

Share on Twitter Share on Facebook Share on Linkedin
neck_pain.jpg
The U.S. Department of Justice said Wisconsin-based Apple Clinic and its owner Michael Johnson, MD, were using a combination of nerve density testing, vitamin injections and electrical stimulation to alleviate pain, billing Medicare for these medically unnecessary services. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Researchers: Online ICD message board littered with inaccuracies
Weekend Edition | April 7, 2018
Female physicians earned $105K less than men in 2017; cardiologists No. 6 in pay

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …345
    • Page 346
    • Page 347
    • Page 348
    • Page 349
    • Page 350
    • Page 351
    • Page 352
    • Current page 353
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup